Intera Atlas
Run match
Sites / Clinical Research of West Florida
Is this you?

Request access for Clinical Research of West Florida with your @crwf.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Clinical Research of West Florida

Unclaimed profile

Independent Network · Tampa, FL · ~2 sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 7Lift (cardio sample) 0.25Recruit soph 0.29
Quality Scorecard (1–100)
Overall81Recruit65Ops84Sponsor91Ther88

Performance (observed)

Historical trials
500
Completed
305
Terminated/Withdrawn
62
Completion rate
83%
Active now
125
Phase 2
137
Phase 3
300
Realized enrollment
475,055
First study year
1995
Years active
31
Match confidence
high
Enrollment velocity (inf)
15,324

Therapeutic

Areas
Dermatology, Rheumatology, Gastroenterology, Pulmonology, Cardiology, Allergy/Asthma, Pain Management, Rheumatoid Arthritis, COPD, Psoriatic Arthritis, Lupus, Vaccines
Specialties
Pulmonology, Rheumatology, Dermatology, Cardiology, Gastroenterology, Orthopedics, Ophthalmology, Pain Management, Allergy/Asthma, Nephrology, Gynecology, Urology, Cannabinoid
Breadth (conditions)
774
Languages
English/Spanish
States
FL

Recruitment (web observed)

Trial Finder
Yes
Advertises recruitment
Yes
Capability notes
Strong patient recruitment and retention; rapid study startup; high-quality data collection; conducts traditional, vaccine, observational, virtual, and decentralized clinical trials

Relationships

Sponsors
Pfizer; AbbVie; National Cancer Institute (NCI); Hoffmann-La Roche; Gilead Sciences; Eli Lilly and Company
CROs
Clinipace Worldwide; ICON Clinical Research; IQVIA Biotech; IQVIA Pty Ltd; IQVIA Pvt. Ltd; Laboratorios Liconsa
Owner / parent
Female-founded (Lynne Merriam, founder); private; Aydin Keskiner (VP/Owner since 2002)

Capacity & people

Investigators
—
Coordinators
—
CEO
Aydin Keskiner
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
info@crwf.com, research@crwf.com

Tech & DCT

eSource
Yes
eConsent
Yes
Builds tech
Unknown
DCT / decentralized
N
Tech stack
Electronic infrastructure mentioned; supports DCT capability
Recruiting visible
Y

Notes

Female-founded, established organization (founded 1995, 1,000+ protocols, 12,000+ patients screened). Small footprint (2-3 sites in Tampa Bay) but strong execution. Multi-specialty focus and explicit DCT/virtual trial capability indicates innovation. Active patient recruitment with compensation-driven enrollment. Multiple current studies visible (COPD, arthritis, lupus). Good recruitment velocity and retention. Lacks broader geographic scale and internal tech development.

Recommendation features (sample indication)

Ind fit 0.35Liftability 0.25Overall81

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.